Case Updates
Tenth Circuit reverses district court’s summary-judgment ruling for Genentech, rejecting the district court’s conclusion that federal law preempts plaintiffs’ state-law claims
May 29, 2020
Click here to view the opinion. The U.S. Chamber filed a brief urging the court to affirm the district court’s ruling.
U.S. Chamber urges Tenth Circuit to hold that federal law preempts state-law claims challenging statements on a prescription drug’s label concerning the amount of the drug included in a vial
October 11, 2019
Click here to view the Chamber’s amicus brief.
Jeremy M. Bylund, Jeffrey S. Bucholtz, Marisa C. Maleck, and Gabriel Krim of King & Spalding LLP served as co-counsel for the U.S. Chamber of Commerce on behalf of the U.S. Chamber Litigation Center.
Case Documents
- Appellants' Opening Brief (Redacted) -- In re MDL 2700 Genentech, Inc. Herceptin (Traztuzumab) Marketing and Sales Litigation (Tenth Circuit).pdf
- U.S. Chamber Amicus Brief -- In re MDL 2700 Genentech, Inc. Herceptin (Traztuzumab) Marketing and Sales Litigation (Tenth Circuit).pdf
- Opinion -- In re MDL 2700 Genentech, Inc. Herceptin (Traztuzumab) Marketing and Sales Litigation (Tenth Circuit).pdf